Giuseppe Rosano

Giuseppe Rosano

Consultant Cardiologist and Professor of Cardiology (Hon)

MD PhD

St George’s University Medical School of London, London, UK

  • LinkedIn
  • Radcliffe
  • OrcidID

Biography

Giuseppe Rosano was born and raised in Vibo Valentia, Italy, where he developed an early interest in medicine and cardiovascular science. While detailed information about his family and early childhood is not widely published, his Italian background and international academic career reflect strong cultural roots combined with global engagement in cardiovascular medicine.

 

Academic History

Professor Rosano obtained his Medical Degree in Medicine and Surgery with full honours from La Sapienza University of Rome in 1988. He subsequently completed his specialisation in Cardiology in 1992. Following his clinical training, he pursued advanced academic and research qualifications in the United Kingdom, earning both an MSc and a PhD in Medical Sciences from Imperial College London. His postgraduate research focused on cardiovascular physiology and pharmacology, forming the foundation of his future work in heart failure and cardiac metabolism.

 

Career Overview

Professor Rosano is a Consultant Cardiologist and Professor of Cardiology at St George’s, University of London, where he also serves as Director of the MSc in Heart Failure. Alongside his UK appointments, he has held academic roles in Italy and has been actively involved in European regulatory and advisory bodies.

He has served as a core member of the Cardiovascular Working Party of the European Medicines Agency and as a member of the Pricing and Reimbursement Committee of the Italian Drug Agency, contributing to regulatory decisions on cardiovascular medicines. His academic leadership extends to editorial responsibilities, serving on the editorial boards of leading international journals including European Journal of Heart Failure, European Heart Journal – Cardiovascular Pharmacotherapy, Cardiac Failure Review, and Cardiovascular Diabetology. He is also Deputy Editor-in-Chief of Cardiac Failure Review.

Professor Rosano’s research and clinical interests include heart failure, cardiac metabolism, cardiovascular pharmacology and pharmacotherapy, heart disease in women, and the cardiovascular effects of sex hormones. He has a particular focus on chronic coronary syndromes and angina in patients with normal coronary arteries, areas in which he is regarded as a leading international authority.

Over the course of his career, Professor Rosano has authored more than 500 peer-reviewed scientific articles, as well as eight books and 32 book chapters, and is a frequent invited speaker at major international cardiology conferences.

 

Career Timeline

  • 1988 – Awarded Medical Degree from La Sapienza University of Rome
  • 1992 – Completed specialisation in Cardiology
  • 1990s – Completed MSc and PhD in Medical Sciences at Imperial College London
  • 2000s–Present – Consultant Cardiologist and Professor of Cardiology, St George’s, University of London
  • 2010s – Member, Cardiovascular Working Party, European Medicines Agency
  • 2022–2023 – President, Heart Failure Association of the European Society of Cardiology
  • Current – Director, MSc Heart Failure; Deputy Editor-in-Chief, Cardiac Failure Review

 

Recognition

Professor Rosano is internationally recognised for his contributions to cardiovascular medicine and heart failure research. His work has placed him among the most influential scientists globally based on citation impact and scholarly output. He is widely respected for his leadership in European cardiovascular research, education, and regulatory science.

 

Areas of Speciality

  • Heart Failure
  • Cardiac Metabolism
  • Cardiovascular Pharmacology and Pharmacotherapy
  • Heart Disease in Women
  • Chronic Coronary Syndromes
  • Angina with Normal Coronary Arteries
  • Cardiovascular Effects of Sex Hormones

 

Sources

Read more

Media

Giuseppe Rosano, John R Teerlink, Koichiro Kinugawa

Watch time: 35m 53s (4 videos)
Managing the patients with CRM: who gets what, when and why?

Gianluigi Savarese, Alice Cheng, Adeera Levin, et al

Watch time: 59m 47s
Guideline directed therapy for CRM disease: the evidence base

Intissar Haddiya, Lars H Lund, Marco Metra, et al

Watch time: 1h 2m 27s

Giuseppe Rosano, Stephen J Greene

Watch time: 43m 46s

Giuseppe Rosano, Lisa Anderson, Antoni Bayés-Genís

Broadcast

Heart Failure
Reshaping Early Identification and Diagnosis of HF

Giuseppe Rosano, Lisa Anderson, Antoni Bayés-Genís, et al

Watch time: 41m 52s

Vijay Chopra, Deepak L Bhatt, Michelle Wong, et al

Stefan Anker, Giuseppe Rosano, Javier de Juan Bagudá, et al

Watch time: 15h 45m 20s (18 videos)
Heart Failure in Focus Podcast - Ep 8: Making Progress in HFpEF

Muthiah Vaduganathan, Giuseppe Rosano,

Listen time: 21m 15s
2023 ESC Guidelines Update: Acute & Chronic Heart Failure

Giuseppe Rosano, Harriette Van Spall

Watch time: 10m 8s

Carolyn Lam, Giuseppe Rosano

Mikhail Kosiborod, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 49m 50s (8 videos)

Biykem Bozkurt, Giuseppe Rosano

Watch time: 13m 13s (2 videos)

John JV McMurray, Yuhui Zhang, Giuseppe Rosano, et al

Watch time: 17h 35m (23 videos)

Broadcast

Heart Failure

MI/ACS
Valsartan Sacubitril: Has our PARADIGM shifted?

Giuseppe Rosano, Richard Henry P Tiongco, Rungroj Krittayaphong, et al

Watch time: 53m 45s
HF 2022: Heart Failure Highlights of with Prof Rosano

Giuseppe Rosano

Watch time: 2m 40s

Giuseppe Rosano, Mikhail Kosiborod, Biykem Bozkurt

Watch time: 18m 38s (3 videos)

Andrew JS Coats, Giuseppe Rosano

Watch time: 23m 5s (3 videos)

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 5h 14m 55s (31 videos)

Shelley Zieroth, Martin R Cowie, Javed Butler, et al

Watch time: 53m 14s (5 videos)
Sodium–Glucose Co-transporter 2 Inhibitors in Heart Failure: Recent Data and Implications for Practice

Giuseppe Rosano, David Quek, Felipe Martínez, et al

Broadcast

Heart Failure
New Challenges in the Management of Heart Failure: Meet the Experts

Juan Carlos Kaski, Giuseppe Rosano, Alexander Lyon, et al

Watch time: 1h 33m 44s

Broadcast

Heart Failure
New Challenges in the Management of Heart Failure: Meet the Experts

Juan Carlos Kaski, Giuseppe Rosano, Theresa A McDonagh, et al

Watch time: 2h 4m 50s
ESC 2019: DAPA-HF - A perspective - Prof Giuseppe Rosano

Giuseppe Rosano

Watch time: 5m 29s
ESC 2015: True advances in the treatment of heart failure

Giuseppe Rosano

Watch time: 4m 58s

Articles by Giuseppe Rosano, Consultant Cardiologist and Professor of Cardiology (Hon)

Medical Treatment of Heart Failure with Reduced Ejection Fraction in the Elderly

Ivan Milinkovic, Marija Polovina, Andrew JS Coats, et al

Published:

Citation: Cardiac Failure Review 2022;8:e17.

DOI:

https://doi.org/10.15420/cfr.2021.14
Foreword

Andrew JS Coats, Giuseppe Rosano,

Published:

Citation: Cardiac Failure Review 2019;5(2):68–9.

DOI:

https://doi.org/10.15420/cfr.2019.14.1
Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction

Giuseppe Rosano, Ilaria Spoletini, Cristiana Vitale, et al

Published:

Citation: Cardiac Failure Review 2019;5(3):130–2.

DOI:

https://doi.org/10.15420/cfr.2019.8.2
Foreword

Andrew JS Coats, Giuseppe Rosano,

Published:

Citation: Cardiac Failure Review 2019;5(3):128–9.

DOI:

https://doi.org/10.15420/cfr.2019.5.3.FO1
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2019;5(1):4.

DOI:

https://doi.org/10.15420/cfr.2019.4.1
Erratum to: Foreword

Andrew JS Coats, Giuseppe Rosano,

Published:

Citation: Cardiac Failure Review 2019;5(1):62.

DOI:

https://doi.org/10.15420/cfr.2018.34.1
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2018;4(1):4–5

DOI:

https://doi.org/10.15420/cfr.2018.4.1.FO1
Pharmacological Interventions Effective in Improving Exercise Capacity in Heart Failure

Cristiana Vitale, Ilaria Spoletini, Giuseppe Rosano, et al

Citation: Cardiac Failure Review 2018;4(1):25–7.

DOI:

https://doi.org/10.15420/cfr.2018:8:2
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2018;4(2):68-9.

DOI:

https://doi.org/10.15420/cfr.2018.33.1
Metabolic Modulation of Cardiac Metabolism in Heart Failure

Giuseppe Rosano, Cristiana Vitale,

Citation: Cardiac Failure Review 2018;4(2):99–103.

DOI:

https://doi.org/10.15420/cfr.2018.18.2
Frailty in Heart Failure: Implications for Management

Cristiana Vitale, Ilaria Spoletini, Giuseppe Rosano, et al

Citation: Cardiac Failure Review 2018;4(2):104–6.

DOI:

https://doi.org/10.15420/cfr.2018.22.2
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2017;3(2):77–8.

DOI:

https://doi.org/10.15420/cfr.2017:3:2:77
Heart Failure in Patients with Diabetes Mellitus

Giuseppe Rosano, Cristiana Vitale, Petar M Seferovic, et al

Citation: Cardiac Failure Review 2017;3(1):52–5.

DOI:

https://doi.org/10.15420/cfr.2016:20:2
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2017;3(1):5–6

DOI:

https://doi.org/10.15420/cfr.2017:3:1:5
Practical Applications for Single Pill Combinations in the Cardiovascular Continuum

Ferdinando Iellamo, Karl Werdan, Krzysztof Narkiewicz, et al

Citation: Cardiac Failure Review 2017;3(1):40–5.

DOI:

https://doi.org/10.15420/cfr.2017:5:1
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2016;2(1):6-7.

DOI:

https://doi.org/10.15420/cfr.2015.2.1.6
The Role of Ivabradine and Trimetazidine in the New ESC HF Guidelines

Ivan Milinkovic, Giuseppe Rosano, Yury Lopatin, et al

Citation: Cardiac Failure Review, 2016;2(2):123–9

DOI:

https://doi.org/10.15420/cfr.2016:13:1
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2016;2(2):78.

DOI:

https://doi.org/10.15420/cfr.2016:2:2:ED1
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2015:1(2):62-3.

DOI:

https://doi.org/10.15420/cfr.2015.1.2.62
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2015:1(1):6-7.

DOI:

https://doi.org/10.15420/cfr.2015.01.01.6
Sodium–Glucose Co-transporter 2 Inhibitors in Heart Failure: Recent Data and Implications for Practice

Giuseppe Rosano, David Quek, Felipe Martínez, et al

Published:

Citation: Cardiac Failure Review 2020;6:e31.

DOI:

https://doi.org/10.15420/cfr.2020.23

Keywords

Hypertension, Exercise Physiology, Insulin Resistance, Exercise Testing, Atrial Fibrillation, Blood Pressure, Exercise Intervention, Cardiology, Interventional Cardiology, Diabetes Mellitus, Metabolic Syndrome, Vascular Diseases, Endothelial Dysfunction, Endothelial Function, Pharmaceutical Care, Regulatory Affairs, Exercise Therapy, Pharma Sciences